DM0000: The mark consists of the letters "cbc" at the top of the mark with the first "c" being black, the "b", from left to right, being mostly black with two diagonal white stripes and then the remainder light green, the second "c" is light green turning green at the bottom; six green dots are in a vertical stack below the first "c" and to their right in black is the wording "Comprehensive Biomarker Center".
CC0000: The color(s) black, white, green and light green is/are claimed as a feature of the mark.
GS0351: professional business consultation and business organization consultation in the market authorization of medicines and medical devices; planning and conducting of trade fairs for economic or advertising purposes; import-export agencies in the field of medicines and medical devices; wholesale store services and retail store services featuring medicines; business marketing services related to medicines and medical devices; commercial information and advice for consumers; wholesale store services in the chemical products sector featuring chemical and biochemical reagents for genetic analysis and testing; market reports and studies
GS0441: Medical services; veterinary services; hygienic and beauty care for human beings or animals; medical and veterinary diagnostic services in preclinical and clinical settings; medical and clinical examinations
D10000: "COMPREHENSIVE BIOMARKER CENTER"
GS0421: scientific and technological services, namely, scientific research, analysis and testing in the field of medicine, genetics and medical biomarkers; testing, analysis, and evaluation of medical diagnostic and biomarker preparations to assure compliance with industry standards; industrial chemical, biochemical, biological and bacteriological research and analysis; medical and scientific research information in the field of medicine, genetics and medical biomarkers; research and development of vaccines and medicines; design and testing for new product development, namely, pharmaceutical and diagnostic preparations and substances; development of pharmaceutical preparations and medicines; research and development of vaccines and medicines; testing, analyzing and evaluating new medicines; chemical research laboratories, pharmaceutical research laboratories, medical research laboratories, bacteriology research laboratories, molecular biological/biological research laboratories; medical and scientific research, namely, conducting clinical trials for others; scientific analyses in the field of chemistry, biology, molecular biology, pharmaceutics, and food technology; computer development of software in the field of the operation of therapeutic and diagnostic equipment and for the data processing for the purpose of imaging; scientific and technological services, namely, scientific research particular in the field of chemistry, genetics, biology, bioengineering, and biochemistry; chemical, biochemical, biological and bacteriological research and analysis; DNA and RNA analysis services, namely, development and research of DNA, RNA and scientific research in the field of biochemistry and biotechnology; scientific research; preparation of scientific opinions in the field of scientific research and development; advisory services relating to biotechnology, pharmaceutical research and development and genetic science; medical and scientific research, namely, the extraction or cultivation, scientific processing, and scientific analysis of biomaterials and compiling data for research purposes in the field of medical science and medical consultancy; contract research in the field of pharmacological and clinical development of medicines; scientific data analysis for scientific and technical purposes, namely, analysis of data originating from clinical trials; scientific laboratory services, namely, scientific development, research, identification, validation, analysis and interpretation of biomarkers, particularly nucleic acid based biomarkers
Case File Event Statements
11/13/2022 - 2 years ago
43 - NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILEDType:DENC
11/13/2022 - 2 years ago
42 - DEATH OF INTERNATIONAL REGISTRATIONType:DETH
2/5/2022 - 2 years ago
41 - TOTAL INVALIDATION PROCESSED BY THE IBType:INNT
1/11/2022 - 3 years ago
40 - TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IBType:INTS
1/11/2022 - 3 years ago
39 - INVALIDATION PROCESSEDType:INPC
10/26/2021 - 3 years ago
38 - TOTAL INVALIDATION OF REG EXT PROTECTION CREATEDType:INTR
2/26/2021 - 3 years ago
37 - CANCELLED SECTION 71Type:C71T
6/9/2016 - 8 years ago
36 - NEW REPRESENTATIVE AT IB RECEIVEDType:NREP
10/28/2014 - 10 years ago
35 - CORRECTION FROM THE IB EXAMINED, NO ACTION IS NEEDEDType:CORN
10/23/2014 - 10 years ago
34 - CORRECTION TRANSACTION RECEIVED FROM IBType:CRCV
6/27/2014 - 10 years ago
33 - FINAL DECISION TRANSACTION PROCESSED BY IBType:FINO
6/11/2014 - 10 years ago
32 - FINAL DISPOSITION NOTICE SENT TO IBType:FICS
6/10/2014 - 10 years ago
31 - FINAL DISPOSITION PROCESSEDType:FIMP
5/25/2014 - 10 years ago
30 - FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IBType:FICR
5/6/2014 - 10 years ago
29 - CORRECTION FROM IB ENTERED - NO REVIEW REQUIREDType:CORR
4/24/2014 - 10 years ago
28 - CORRECTION TRANSACTION RECEIVED FROM IBType:CRCV
2/25/2014 - 10 years ago
27 - REGISTERED-PRINCIPAL REGISTERType:R.PR
2/2/2014 - 10 years ago
26 - NOTIFICATION PROCESSED BY IBType:GPNX
12/23/2013 - 11 years ago
25 - CHANGE OF OWNER RECEIVED FROM IBType:CHLD
12/10/2013 - 11 years ago
24 - PUBLISHED FOR OPPOSITIONType:PUBO
11/20/2013 - 11 years ago
23 - NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IBType:OPNS
11/20/2013 - 11 years ago
22 - NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IBType:OP2R
11/20/2013 - 11 years ago
21 - NOTICE OF PUBLICATIONType:NPUB
11/4/2013 - 11 years ago
20 - LAW OFFICE PUBLICATION REVIEW COMPLETEDType:PREV
10/25/2013 - 11 years ago
19 - ASSIGNED TO LIEType:ALIE
10/10/2013 - 11 years ago
18 - APPROVED FOR PUB - PRINCIPAL REGISTERType:CNSA
9/21/2013 - 11 years ago
17 - TEAS/EMAIL CORRESPONDENCE ENTEREDType:TEME
9/20/2013 - 11 years ago
16 - CORRESPONDENCE RECEIVED IN LAW OFFICEType:CRFA
9/20/2013 - 11 years ago
15 - TEAS RESPONSE TO OFFICE ACTION RECEIVEDType:TROA
3/26/2013 - 11 years ago
14 - NON-FINAL ACTION MAILEDType:CNRT
3/26/2013 - 11 years ago
13 - NON-FINAL ACTION WRITTENType:CNRT
3/4/2013 - 11 years ago
12 - TEAS/EMAIL CORRESPONDENCE ENTEREDType:TEME
3/4/2013 - 11 years ago
11 - CORRESPONDENCE RECEIVED IN LAW OFFICEType:CRFA
3/4/2013 - 11 years ago
10 - TEAS RESPONSE TO OFFICE ACTION RECEIVEDType:TROA
11/15/2012 - 12 years ago
9 - REFUSAL PROCESSED BY IBType:RFNT
10/22/2012 - 12 years ago
8 - NON-FINAL ACTION MAILED - REFUSAL SENT TO IBType:RFCS
10/22/2012 - 12 years ago
7 - REFUSAL PROCESSED BY MPUType:RFRR
10/20/2012 - 12 years ago
6 - NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEWType:RFCR
10/19/2012 - 12 years ago
5 - NON-FINAL ACTION WRITTENType:CNRT
10/19/2012 - 12 years ago
4 - APPLICATION FILING RECEIPT MAILEDType:MAFR
10/15/2012 - 12 years ago
3 - ASSIGNED TO EXAMINERType:DOCK
10/15/2012 - 12 years ago
2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAMType:NWOS
10/11/2012 - 12 years ago
1 - SN ASSIGNED FOR SECT 66A APPL FROM IBType:REPR
Trademark
79118333
